What We Need to Know: Express Scripts Q4 Earnings
It used the earning's call to pass much of the blame for high drug prices onto pharmaceutical companies.
Pharmacy benefit manager Express Scripts (ESRX) used the earning's call to pass much of the blame for high drug prices onto pharmaceutical companies. One statistic that stuck out: While prices of branded drugs increased 11% in 2016, the company kept the increase at 2.5% for its clients. Express Scripts' shares were steady following the call. Prices have increased just 1.35% this year.
